The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities
Abstract
In this study we present incidence, point prevalence, and mortality figures of mitochondrial encephalomyopathies in a population‐based study of children from western Sweden. Through the screening of registers and review of medical records, we identified 32 patients under 16 years of age from the study population who were diagnosed between January 1, 1984, and December 31, 1998. The incidence of mitochondrial encephalomyopathies in preschool children (<6 years of age) was 1 out of 11,000. The preschool incidence of Leigh's syndrome was 1 out of 32,000, and the preschool incidences of both Alper's syndrome and infantile mitochondrial myopathy with cytochrome C oxidase deficiency were 1 out of 51,000. The point prevalence (January 1, 1999) of mitochondrial encephalomyopathies in children under 16 years of age was 1 out of 21,000. The median survival for patients with infantile onset was until 12 years of age. We identified 4 cases with mitochondrial DNA point mutations, 2 cases with mitochondrial DNA deletions, and 2 cases with nuclear mutations in the SURF1 gene. We conclude that mitochondrial encephalomyopathies are relatively common neurometabolic disorders in childhood. Ann Neurol 2001;49:377–383
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT
Leigh, D. (1951) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.14.3.216 · Cited by 786
Leigh syndrome: Clinical features and biochemical and DNA abnormalities
Rahman, S., Blok, R. B., Dahl, H. ‐. M., Danks, D. M., Kirby, D. M., Chow, C. W., Christodoulou, J., & Thorburn, D. R. (1996) · Annals of Neurology · doi:10.1002/ana.410390311 · Cited by 778
DiMauro, S., Bonilla, E., Zeviani, M., Nakagawa, M., & DeVivo, D. C. (1985) · Annals of Neurology · doi:10.1002/ana.410170602 · Cited by 688
MELAS: Clinical features, biochemistry, and molecular genetics
Ciafaloni, E., Ricci, E., Shanske, S., Moraes, C. T., Silvestri, G., Hirano, M., Simonetti, S., Angelini, C., Donati, M. A., Garcia, C., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410310408 · Cited by 500
The clinical features of mitochondrial myopathy
PETTY, R. K. H., HARDING, A. E., & MORGAN-HUGHES, J. A. (1986) · Brain · doi:10.1093/brain/109.5.915 · Cited by 417
The Molecular and Genetic Basis of Neurological Disease
TROJANOWSKI, J. Q. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199309000-00013 · Cited by 341
Progressive Increase of the Mutated Mitochondrial DNA Fraction in Kearns-Sayre Syndrome
Larsson, N.-G., Holme, E., Kristiansson, B., Oldfors, A., & Tulinius, M. (1990) · Pediatric Research · doi:10.1203/00006450-199008000-00011 · Cited by 324
Self-citationCalculating Confidence Intervals for Rates and Ratios
Schoenberg, B. S. (1983) · Neuroepidemiology · doi:10.1159/000110529 · Cited by 218
Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden
Darin, N., & Tulinius, M. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00055-3 · Cited by 205
Self-citation
Cited by
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.80 · Cited by 1,563
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 907
Mitochondria, oxidative stress and neurodegeneration
Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 787
Pathogenic Mitochondrial DNA Mutations Are Common in the General Population
Elliott, H. R., Samuels, D. C., Eden, J. A., Relton, C. L., & Chinnery, P. F. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.004 · Cited by 628
Schapira, A. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68970-8 · Cited by 591
mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome
Johnson, S. C., Yanos, M. E., Kayser, E.-B., Quintana, A., Sangesland, M., Castanza, A., Uhde, L., Hui, J., Wall, V. Z., Gagnidze, A., et al. (2013) · Science · doi:10.1126/science.1244360 · Cited by 512
Treatment for mitochondrial disorders
Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D., & Chinnery, P. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004426.pub3 · Cited by 492
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., et al. (2004) · Pediatrics · doi:10.1542/peds.2004-0718 · Cited by 466
The epidemiology of mitochondrial disorders—past, present and future
Schaefer, A. M., Taylor, R. W., Turnbull, D. M., & Chinnery, P. F. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.09.005 · Cited by 396
Chinnery, P. F., & Hudson, G. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt017 · Cited by 395
DiMauro, S., & Davidzon, G. (2005) · Annals of Medicine · doi:10.1080/07853890510007368 · Cited by 363
mTOR in Brain Physiology and Pathologies
Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 356
El-Hattab, A. W., & Scaglia, F. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0177-6 · Cited by 335
MELAS: A nationwide prospective cohort study of 96 patients in Japan
Yatsuga, S., Povalko, N., Nishioka, J., Katayama, K., Kakimoto, N., Matsuishi, T., Kakuma, T., & Koga, Y. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.015 · Cited by 306
Recent Advances in Mitochondrial Disease
Craven, L., Alston, C. L., Taylor, R. W., & Turnbull, D. M. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035426 · Cited by 288
Barret, B., Tardieu, M., Rustin, P., Lacroix, C., Chabrol, B., Desguerre, I., Dollfus, C., Mayaux, M.-J., & Blanche, S. (2003) · AIDS · doi:10.1097/00002030-200308150-00006 · Cited by 281
Mitochondrial Disease: A Practical Approach for Primary Care Physicians
Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., & Cohen, B. H. (2007) · Pediatrics · doi:10.1542/peds.2007-0391 · Cited by 273
Self-citationMitochondrial disorders: prevalence, myths and advances
Thorburn, D. R. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031098.41409.55 · Cited by 258
“While this ¢gure is clearly still likely to be an underestimate, it is comparable to the only two previous estimates of childhood-onset OXPHOS disorders of 3.2/100 000 (95% CI 1.7� 5.5) in British Columbia (Applegarth et al 2000) and 8.9/100 000 births (95% CI 5.3� 14.0) in western Sweden ( Darin et al 2001 ), both st…”
ResultInfluentialMitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations
Ostergaard, E., Hansen, F. J., Sorensen, N., Duno, M., Vissing, J., Larsen, P. L., Faeroe, O., Thorgrimsson, S., Wibrand, F., Christensen, E., et al. (2007) · Brain · doi:10.1093/brain/awl383 · Cited by 188
Sörensen, L., Ekstrand, M., Silva, J., Lindqvist, E., Xu, B., Rustin, P., Olson, L., & Larsson, N.-G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08082.2001 · Cited by 167
Mitochondrial disease in adults: what's old and what's new?
Chinnery, P. F. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505079 · Cited by 133
Ware, S. M., El-Hassan, N., Kahler, S. G., Zhang, Q., Y-W, Miller, E., Wong, B., Spicer, R. L., Craigen, W. J., Kozel, B. A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063149 · Cited by 86
Nutritional interventions in primary mitochondrial disorders: Developing an evidence base
Camp, K. M., Krotoski, D., Parisi, M. A., Gwinn, K. A., Cohen, B. H., Cox, C. S., Enns, G. M., Falk, M. J., Goldstein, A. C., Gopal-Srivastava, R., et al. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.09.002 · Cited by 59
PKC downregulation upon rapamycin treatment attenuates mitochondrial disease
Martin-Perez, M., Grillo, A. S., Ito, T. K., Valente, A. S., Han, J., Entwisle, S. W., Huang, H. Z., Kim, D., Yajima, M., Kaeberlein, M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00319-x · Cited by 45
Metadata
- Authors
- Darin, N., Oldfors, A., Moslemi, A., Holme, E., & Tulinius, M.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-03
- Volume
- 49
- Issue
- 3
- Pages
- 377-383
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2059282884
- Cited by
- 362
- References
- 26
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.